Global Electronic Trial Master File (eTMF) Systems market is expected to witness a growth of CAGR 12% by the next 5 years

 

Increasing number of clinical trials, a surge in the volume of data generated, and an increase in the number of eTMF system users are some of the key factors driving the eTMF systems market. However, inadequate trained professionals and clinical data privacy are some of the challenges that are likely to hamper the global eTMF Systems Market growth.

Electronic Trial Master File (eTMF) is a content management system for the Bio-Pharma industry which includes protocols, strategies, and tools used throughout the lifecycle of the clinical trial. An eTMF digitally captures, shares, and stores the essential documents and content generated in a clinical trial.

Increasing Adoption due to benefits Offered by eTMF Systems drive the Electronic Trial Master File (eTMF) Systems

Post Covid-19 pandemic, the number of clinical trials and volume of data generated increased exponentially, which in turn has fueled the adoption of eTMF systems by Bio-Pharma companies. The eTMF systems give real-time visibility of the clinical trial data and activities conducted at scattered sites across the globe. The benefits of adopting eTMF are increased business efficiency, speedup timelines, reduced cost and risk. For instance,

§  In June 2022, Anju Software Inc., announced the introduction of its new cloud-based eTMF product. The product will expedite the collaboration between CRO’s, sponsor and sites to manage the clinical data efficiently in a regulatory-compliant environment.


Resurgence of Electronic Trial Master File (eTMF) Systems Post Pandemic Drives the Electronic Trial Master File (eTMF) Systems Market

The Covid-19 Pandemic has triggered a change in execution of the clinical trials. Due to travel bans and lockdowns, virtual clinical trials were initiated by Bio-Pharma companies by adopting remote patient monitoring, telehealth, wearable devices and apps to ensure the patient safety. The vast number of clinical trials conducted for rapid development of vaccines during the pandemic had also burdened the healthcare sector. With rise in the number of trials and its data, there was a shift from manual TMF systems to eTMF systems, for seamless management of data in decentralized clinical trials. The other factor which had set in motion this shift was the clinical data retention regulation policy to maintain the data for 25 years by the Sponsors/CRO’s.

North America Expected to Continue to Hold a Major Share in the Electronic Trial Master File (eTMF) Systems Market

From a geographical perspective, North America holds a major market share of the Electronic Trial Master File (eTMF) Systems market. This can be Primarily attributed to the growing number of clinical trials & volume of data generated, favorable funding environment to support clinical trials, well-developed healthcare IT infrastructure, and presence of several key players in the region However, the Asia-Pacific region is expected to witness strong growth in the coming years due to flourishing Biopharma industry, growing outsourcing of clinical trials in the region, and rapid development of vaccines by Biopharma industry due to Covid-19 Pandemic.

Competitive Landscape : Electronic Trial Master File (eTMF) Systems Marke

Some of the key players operating in the market include Veeva Systems, Aris Global LLC, Master Control, Inc., Montrium, Clinevo Technology, Oracle Corporation, Phlexglobal, Transperfect, Aurea Software, Labcorp (Covance, Inc.) and Sureclinical, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Electronic Trial Master File (eTMF) Systems Market

The players operating in this market are adopting organic and inorganic growth strategies such as launching new products/technologies, collaborations, and acquisitions to garner higher market share. For instance,

§  In February 2023, TransPerfect Life Sciences announced that Surrozen has selected its Trial Interactive eClinical platform, including electronic Trial Master File (eTMF) and TMF solutions to create a centralized, quality-focused approach to TMF management

The Electronic Trial Master File (eTMF) Systems is a growing market that is expected to gain further momentum in the coming years with growing adoption of the eTMF systems, rising R&D investments by pharma-biotech companies, favorable government funding & grants to support clinical trials, and aggressive organic and inorganic growth strategies followed by the players.

Get Detailed Insights on the Electronic Trial Master File (eTMF) Systems market @ https://meditechinsights.com/electronic-trial-master-file-etmf-systems-market/

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global 3D Cell Culture Market Seeks Prosperous Horizon: Double-Digit Growth Expected by 2027

Image
  The need for organ transplants and tissue engineering combined with developments in scaffold-free technology, a rise in investments and research and development (R&D) funding for cell-based studies, growing efforts to develop potential alternatives to animal-based testing, and the rising incidence of chronic diseases are some of the major factors propelling the growth of the global 3D cell culture market. 3D cell culture   is an important approach in cell biology and tissue engineering because it includes cultivating and analyzing cells in a three-dimensional environment that mimics the circumstances present in the human body. It has several advantages, such as the capacity to recreate in vivo settings, allow the creation of complex multicellular structures, and give realistic drug testing situations. Scaffold-based technologies employing materials such as hydrogels are employed for 3D cell culturing. Its uses include cancer research, tissue engineering, and medication d...
Read more

Global Tricuspid Valve Repair Market Driven by Innovation: Set to Surge with a US$2.5 Billion Market by 2028

Image
  Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcatheter tricuspid valve repair (TTVR), increased clinical research and trials activities for developing new tricuspid valve repair technologies, and rising incidence of tricuspid valve disorders are some of the key factors driving the global tricuspid valve repair market. • Medical technology advancements in the field of cardiac interventions. • Improved awareness of heart valve disorders. One of the four valves in our heart that regulates blood flow is the tricuspid valve . It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close. Tricuspid valve illnesses are disorders that some people have that impair the tricuspid valve's a...
Read more